October 21st 2023.
The SRM Centre for Clinical Trials and Research has recently been approved by the Indian Council for Medical Research (ICMR) to carry out Phase 1 drug trials. This is a great recognition for SRM Medical College Hospital and Research Centre as they were the only private medical college and healthcare institution to be selected out of more than 30 prestigious and premier institutions.
Dr. P.Sathyanarayanan, Pro-Chancellor of SRM, expressed his pride and recognition for their commitment to quality and pursuit of excellence. He said, “It is a matter of great pride and recognition to our commitment to quality and pursuit of excellence which has yielded such results.”
The process of selecting the suitable institution for the Phase 1 clinical trial infrastructure began in June 2022. ICMR assessed institutions on the basis of their infrastructure, capabilities, experience, manpower and other resources.
Dr. Satyajit Mohapatra, Director CCTR of SRM, explained the importance of Phase 1 trials. He said, “Phase 1 is important as it is the stage where drugs are tested for their safety and a safe dose is selected for the next phase of development.” He further added that the ICMR had rolled out its CARE scheme to encourage in-depth research and these CARE facilities will be national assets that will immensely help Indian researchers working in drug discovery and development.
The SRM Centre for Clinical Trials and Research has put in a lot of hard work to get selected for the Phase 1 clinical trials. They had to present their infrastructure and experience, and also face site visits and inspection by the ICMR team and a technical review committee. It is a great achievement for the SRM Medical College Hospital and Research Centre and ICMR’s approval is a mark of recognition for their commitment to quality and pursuit of excellence.
[This article has been trending online recently and has been generated with AI. Your feed is customized.]
